Suven Life Sciences Limited — Updates, 08-07-2026: General Updates
08-07-2026 | 04:51 pm
08-07-2026 | 04:51 pm
Suven Life Sciences allotted 1.86 Cr shares via warrant conversion, raising ₹248.84 Cr, significantly boosting its paid-up capital. The company is also incorporating a Singapore subsidiary for biopharmaceutical clinical development, involving an investment of up to $100M.
No comments yet. Be the first to comment!
